SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...

Sumatriptan Succinate Injection is indicated for 1) the acute treatment of migraine attacks with or without aura and 2) the acute treatment of cluster headache episodes. Sumatriptan Succinate ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL For Subcutaneous Use, a ...

April 6, 2007 — Results of 2 randomized studies assessing a fixed-dose tablet combining sumatriptan and naproxen ( Trexima, Pozen Inc/GlaxoSmithKline) suggest that the combination offers more ...

Drug maker Ranbaxy Laboratories said it has received final approval of the US health watchdog to manufacture and market in the country Sumatriptan Succinate Tablets used for the treatment of migraine ...

HYDERABAD, India — Dr. Reddy's Labs announced that it has launched Sumatriptan Injection USP, Autoinjector System 6-mg/0.5-mL, a generic version of Imitrex STATdose Pen (sumatriptan succinate) ...

MISSISSAUGA, ON, Sept. 9, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI); (OTCQX: NRIFF), a Canadian focused healthcare company with global reach and a diversified ...

Pune, Maharashtra, January 28 2021 (Wiredrelease) Market.Biz –:Sumatriptan Succinate Businesses must navigate the financial and operational challenges of coronavirus while rapidly addressing the needs ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval ...

A subsidiary of Sun Pharmaceutical Industries has received approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of Sumatriptan ...